Science & Technology
Use tab to navigate through the menu items.
Nov 6, 2020
Rich Small, Chief Executive Officer presents at Eyecelerator 2020 Virtual Conference
Sep 30, 2020
Rich Small, Chief Executive Officer presents at Ophthalmology Futures Retina Forum
Feb 12, 2019
Neurotech Pharmaceuticals, Inc. Granted Fast Track
Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2. View...
Jan 16, 2019
Neurotech Announces Publication of NT-501 Phase 2 Results.
View PDF Version